1. The Schering Corp. v. Geneva Pharmaceuticals, Inc. case ruled that a patent for a metabolite produced naturally in the human body upon consumption of another patented drug was invalid since the metabolite's production was inherent and anticipated by the original drug patent.
2. In re Wands established that while some experimentation is allowed, a patent must provide enough guidance such that the necessary experimentation is not undue for one skilled in the art.
3. Aguas v. De Leon upheld a patent for an improved tile-making process, finding it was inventive and went beyond mechanical skill to introduce a new product for a new purpose with improved durability over prior methods.
1. The Schering Corp. v. Geneva Pharmaceuticals, Inc. case ruled that a patent for a metabolite produced naturally in the human body upon consumption of another patented drug was invalid since the metabolite's production was inherent and anticipated by the original drug patent.
2. In re Wands established that while some experimentation is allowed, a patent must provide enough guidance such that the necessary experimentation is not undue for one skilled in the art.
3. Aguas v. De Leon upheld a patent for an improved tile-making process, finding it was inventive and went beyond mechanical skill to introduce a new product for a new purpose with improved durability over prior methods.
1. The Schering Corp. v. Geneva Pharmaceuticals, Inc. case ruled that a patent for a metabolite produced naturally in the human body upon consumption of another patented drug was invalid since the metabolite's production was inherent and anticipated by the original drug patent.
2. In re Wands established that while some experimentation is allowed, a patent must provide enough guidance such that the necessary experimentation is not undue for one skilled in the art.
3. Aguas v. De Leon upheld a patent for an improved tile-making process, finding it was inventive and went beyond mechanical skill to introduce a new product for a new purpose with improved durability over prior methods.
1. The Schering Corp. v. Geneva Pharmaceuticals, Inc. case ruled that a patent for a metabolite produced naturally in the human body upon consumption of another patented drug was invalid since the metabolite's production was inherent and anticipated by the original drug patent.
2. In re Wands established that while some experimentation is allowed, a patent must provide enough guidance such that the necessary experimentation is not undue for one skilled in the art.
3. Aguas v. De Leon upheld a patent for an improved tile-making process, finding it was inventive and went beyond mechanical skill to introduce a new product for a new purpose with improved durability over prior methods.
Geneva Schering owned two patents Inherency is not necessarily
Pharmaceuticals, Inc. (loratadine and the DCL coterminous with the metabolite in that knowledge of those of loratadine). Upon the ordinary skill in the art. The expiration of the loratadine knowledge that the human patent, companies sought to body naturally produces the make a generic version. But metabolic DCL upon the Schering claimed the validity ingestion of loratadine was of the DCL metabolite patent. only known in 1984 or at a time later than the grant of The court ruled that the the patent. metabolite patent was invalid since it was naturally inherent and anticipated by the loratadine patent. Human consumption of loratadine necessarily results in the natural production in the human body of the DCL metabolite. In re Wands The patent board argued that 1. quantity of the data presented by Wands experimentation showed that the production necessary, of high-affinity antibodies 2. amount of direction or unpredictable and unreliable, guidance presented, so that it would require 3. presence or absence of undue experimentation for working examples, one skilled in the art to make 4. nature of the invention, the antibodies. 5. state of the prior art, 6. relative skill of those in The court ruled that the art, enablement is not precluded 7. predictability or by the necessity for some unpredictability of the experimentation such as art, and routine screening. However, 8. breadth of the claims. experimentation needed to practice the invention must not be undue experimentation. Aguas v. De Leon A patent for a new and useful If an inventor is able to improvement in the process invent something which is a of making mosaic pre-cast product or process which tiles was granted to de Leon. goes beyond mechanical skill Aguas claimed that the or ordinary competence, process was not new, useful, then such product of process nor inventive. overcomes the test of obviousness. The Court ruled that Aguas’ improvement is indeed inventive and goes beyond the exercise of mechanical skill. He has introduced a new kind of tile for a new purpose. He has improved the old method of making tiles and pre-cast articles which made the tiles more durable. Hotchkiss v. Greenwood Hotchkiss was granted a Justice Woodbury dissented. patent for inventing an He wrote that innovation improved method of making alone cannot be the exclusive knobs. The improvement issue to be consists in making the knobs considered in the of clay or porcelain. determination of Hotchkiss sued Greenwood patentability. If the pure and for infringement. original rationale of the protection of intellectual The SCOTUS ruled that property were to be strictly Hotchkiss’ use of a new followed, then factors such material was no more than a as public benefit, technology- superficial substitution. It sharing, and improvements was merely formal and in everyday livelihood must destitute of ingenuity or be of equal importance as invention. well. Graham v. John Deere Co. The subject patents related to a spring clamp which permits plow shanks to be pushed upward when they hit obstructions in the soil, and a plastic finger sprayer with a hold-down lid used as a built-in dispenser for containers.